Ocampo Capital leads Kokada’s Seed round to foster growth in the naturally low sugar snack market, capitalizing on rising consumer health trends.
Information on the Target
Kokada, founded by husband-and-wife duo Jared and Breanna, emerged in 2020 to address the increasing demand for naturally low sugar products, as highlighted by a Mintel report indicating that 72% of consumers are making this shift. Their flagship product, coconut spreads made from a few simple ingredients and without added sugars, quickly garnered traction in the North Carolina market, securing placements on grocery store shelves within three months of its launch.
The inception of Kokada was fueled by Breanna’s personal experiences seeking allergen-friendly snacks during her time as a national team volleyball player for Jamaica. Limited by her teammate's severe tree nut allergy, Breanna created Kokada in her kitchen to meet her own needs and those of her friends and family. Both founders are alumni of Duke University, where they played collegiate sports, and later earned their MBA degrees from Wharton, further solidifying their capability to scale Kokada nationally.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The health and wellness snack industry in the United States is witnessing remarkable growth, driven largely by increasing consumer awareness of dietary health. With sugar consumption linked to various health issues, there is a surge in
Similar Deals
Chipotle Mexican Grill → Plantible and CH4 Global
2025
Talis Capital → Oh My Green
2023
Ocampo Capital
invested in
Kokada
in 2023
in a Seed Stage deal